Jane Street’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Jane Street’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,467	Closed	-$4.61K	–	9737
2023 Q2	$4.61K	Buy	+15,467	New	+$4.67K	﹤0.01%	8500
2022 Q2	–	Sell	-71,200	Closed	-$686K	–	11317
2022 Q1	$686K	Buy	+71,200	New	+$638K	﹤0.01%	6881

Jane Street's GRNA Position: Q3 2023 in Review

Jane Street sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 15,467 shares — an estimated $4.61K sold.

Jane Street first reported a position in GRNA in Q1 2022 and held it in 2 quarters. The position peaked at $686K in Q1 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Jane Street reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 15,467 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $4.61K.
Jane Street first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 2 quarters.
Jane Street's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $686K in Q1 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.